Become a Member
Dark Mode
Become a Member
Elections 2024
Elections Fact-Check
Compare Manifestos
Electoral Bonds
Manipur: A Year On
Uncovering Hate
'Trapped' in Russia
Members Only
Neon
More
FIT
Webqoof
My Report
Brand Studio
Indian Diaspora
Entertainment
Opinion
World
Videos
Podcasts
Sports
Law
More
Gender
Climate Change
FAQs
Explainers
Graphic Novels
Education
Quint Lab
Business
Good News
Members' Opinion
Photos
Dark Mode
Become a Member
Home
Elections
Jobs
About Us
T&C
Privacy Policy
BECOME A MEMBER
Created by potrace 1.16, written by Peter Selinger 2001-2019
FOLLOW US ON
About Us
Contact Us
Privacy Policy
ADVERTISEMENT
REMOVE AD
×
×
Antiviral Pill
Anti COVID-19 Drug Without Side Effects Being Developed in India: CDRI
Pfizer’s Anti-Viral Pill Shows Results Within 3 Days of Treatment: Report
ADVERTISEMENT
REMOVE AD
Molnupiravir COVID-19 Treatment Has 'Major Safety Concerns': ICMR Chief
After Pfizer, FDA Authorises Merck’s At-Home Antiviral COVID-19 Pill
EMA Approves Pfizer COVID-19 Pill for Emergency Use: Report
Merck’s COVID Pill Shows Less Efficacy in Updated Data: What's Changed?
Pfizer to Licence Its COVID-19 Pill to Low Income Countries: Report
UK Approves First Antiviral Covid Pill: All You Need To Know
Anti COVID-19 Drug Without Side Effects Being Developed in India: CDRI
Pfizer’s Anti-Viral Pill Shows Results Within 3 Days of Treatment: Report
Molnupiravir COVID-19 Treatment Has 'Major Safety Concerns': ICMR Chief
After Pfizer, FDA Authorises Merck’s At-Home Antiviral COVID-19 Pill
EMA Approves Pfizer COVID-19 Pill for Emergency Use: Report
Merck’s COVID Pill Shows Less Efficacy in Updated Data: What's Changed?
Pfizer to Licence Its COVID-19 Pill to Low Income Countries: Report
UK Approves First Antiviral Covid Pill: All You Need To Know